## Corticosteroid-Induced Psychosis **Key Point:** Corticosteroid-induced psychiatric symptoms are a direct dose-dependent effect of glucocorticoids on the central nervous system, not secondary to metabolic derangements. ### Mechanism of Corticosteroid Psychosis **High-Yield:** Glucocorticoids cross the blood–brain barrier and bind to glucocorticoid receptors (GR) in the limbic system, particularly: - Amygdala (emotional processing) - Hippocampus (memory and stress response) - Prefrontal cortex (executive function) This leads to: 1. **Altered monoamine metabolism** — decreased serotonin and dopamine turnover 2. **Increased glutamatergic activity** — excitatory neurotransmission 3. **GABA dysregulation** — reduced inhibitory tone 4. **Cytokine modulation** — paradoxical neuroinflammation at high doses ### Clinical Features of Corticosteroid Psychosis | Feature | Timing | Severity | Reversibility | | --- | --- | --- | --- | | Insomnia | Day 1–2 | Mild | Complete | | Anxiety/agitation | Day 2–3 | Moderate | Complete | | Mood elevation (hypomania) | Day 3–5 | Moderate | Complete | | Psychosis (hallucinations, delusions) | Day 3–7 | Severe | Complete (if caught early) | | Depression | Week 2+ | Variable | Complete | **Clinical Pearl:** This patient's presentation on day 3 with visual hallucinations and agitation is classic for corticosteroid-induced psychosis. The onset correlates with cumulative dose (hydrocortisone 400 mg/day = 100 mg dexamethasone equivalent, a very high dose). ### Risk Factors for Corticosteroid Psychosis - **Dose:** >40 mg/day prednisolone equivalent (or >100 mg hydrocortisone/day) - **Duration:** Acute high-dose therapy (first 3–7 days) - **Route:** IV administration carries higher risk than oral - **Patient factors:** Prior psychiatric history, female gender, older age - **Drug interactions:** Concurrent stimulants, anticholinergics **Mnemonic:** **PSYCH** — Prednisolone/Prednisone, Steroids, Ypsilateral limbic effects, Cortisol excess, High-dose therapy ### Management 1. **Reduce corticosteroid dose** if clinically feasible (taper to maintenance) 2. **Antipsychotic:** Haloperidol 5–10 mg IM or olanzapine 5–10 mg PO 3. **Benzodiazepine:** Lorazepam 2–4 mg for acute agitation 4. **Sleep hygiene:** Melatonin, avoid stimulants 5. **Monitor:** Symptoms typically resolve within 3–7 days of dose reduction **Warning:** Do NOT attribute this to sepsis, hypoglycemia, or electrolyte abnormalities without ruling out corticosteroid psychosis first. The negative sepsis workup and normal vital signs make infection unlikely. [cite:Harrison 21e Ch 377; KD Tripathi 8e Ch 56]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.